Andrea Burnett-Hartman, PhD, MPH

Senior Investigator

Andrea Burnett-Hartman, PhD, MPH, is a Senior Investigator at the KP Colorado Institute for Health Research with strong experience in multi-site, collaborative research, including the National Institutes of Health sponsored Population-based Research to Optimize the Screening Process (PROSPR), the Cancer Research Network (CRN), and the Kaiser Permanente Research Bank (KPRB). Her research focuses on cancer epidemiology, screening, and prevention, as well as precision medicine approaches in cancer care. Dr. Burnett-Hartman also conducts research aimed at understanding and addressing health disparities in cancer screening and outcomes. Her research is motivated by the opportunity to contribute to the prevention of suffering through optimizing cancer prevention and treatment approaches and ensuring equity in care.

Dr. Burnett-Hartman received her Master of Public Health degree from the University of Michigan and completed her doctoral training in epidemiology at the University of Washington. While in Seattle, she completed her post-doctoral training at the Fred Hutchinson Cancer Research Center.

Dr. Burnett-Hartman is an Affiliate Instructor in the Department of Epidemiology at the University of Washington School of Public Health as well as an Affiliate Investigator at the Fred Hutchinson Cancer Research Center.

Selected Research:

  • A New Prospective U.S. Cohort Set Within the Health Care System Institutions to Study Cancer
  • A collaboration of three Kaiser Permanente regions which will participate in the assembly of a prospective multi-center cohort study. This multi-center cohort study will include 150,000-200,000 cancer free adults and will conduct research into cancer etiology and prevention.

    • Funder: National Cancer Institute
    • Award End Date: 09/24/2028

  • Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems (IMPULSS-2)
  • The major goals of this competitive renewal are to leverage the infrastructure and successful work of IMPULSS-1 by expanding the economic model to include treatment guidance and assess the use of the web-based interactive IMPULSS Toolkit in real-time across multiple diverse health systems.

    • Funder: National Cancer Institute
    • Award End Date: 12/31/2027

  • Surveillance for Outcomes of Genomic Medicine Policies
  • The major goal of this project is to evaluate how policies that impact genomic medicine affect the implementation of precision medicine approaches in health care systems.

    • Funder: National Cancer Institute
    • Award End Date: 06/30/2025

  • Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations (PROSPR II - Lung)
  • The long-term goal of this multi-site center grant is to identify critical gaps in the lung cancer screening process and to design innovative, multilevel interventions to reduce lung cancer mortality, particularly among underserved populations.

    • Funder: National Cancer Institute
    • Award End Date: 03/31/2024

  • PROSPR Coordinating Center (PCC)
  • The goal of the PROSPR Coordinating Center (PCC) is to coordinate the research of PROSPR Research Centers to achieve PROSPR's mission of evaluating and improving the cancer screening process (recruitment, screening, diagnosis, and referral for treatment).

    • Funder: National Cancer Institute
    • Award End Date: 03/31/2023

  • An Observational Study to Evaluate Use of the Nodify XL2 Nodule Risk Stratification Test
  • The major goal of this study is to evaluate the impact of the Nodify XL2 test on management of indeterminate lung nodules in KPCO pulmonology patients.

    • Funder: Biodesix, Inc.
    • Award End Date: 05/31/2023

  • Serrated Colorectal Cancer: An Emerging Disease Subtype
  • The objective of this project is to characterize factors relating to the genetic predisposition, clinical presentation, and prognosis of serrated colorectal cancer.

    • Funder: National Cancer Institute
    • Award End Date: 04/30/2023

  • Kaiser Permanente National Research Bank
  • The KP National Research Bank is a collaboration across all Kaiser regions nationally funded by Kaiser Foundation Health Plan. The goal of the KP National Research Bank is to collect blood samples from 500,000 adult KP members and utilize them, combined with survey data and medical information to create a state-of-the-art resource for genetic and health services research.

    • Funder: Kaiser Foundation Health Plan
    • Study End Date: 12/2023